Local Speakers » Stephen Nicholls
South Australian Health & Medical Research Institute; Royal Adelaide Hospital; & University of Adelaide, SA
Stephen Nicholls MBBS PhD FRACP FACC FESC FAHA FCSANZ
SAHMRI Heart Foundation Heart Disease Theme Leader
South Australian Health & Medical Research Institute
Professor of Cardiology, University of Adelaide
Consultant Cardiologist, Royal Adelaide Hospital
Stephen Nicholls is Professor of Cardiology at the University of Adelaide and the inaugural SAHMRI Heart Foundation Heart Disease Theme Leader at the South Australian Health & Medical Research Institute. Steve undertook his medical degree at the University of Adelaide and completed his medical residency at the Royal Adelaide Hospital. Following advanced training in cardiovascular medicine in Newcastle, he undertook doctoral studies at the Royal Adelaide Hospital and Heart Research Institute focusing on the anti-inflammatory properties of HDL.
He subsequently moved to the Cleveland Clinic to undertake postdoctoral studies of novel imaging modalities of atherosclerotic plaque, supported by the Ralph Reader Overseas Research Fellowship of the National Heart Foundation. He was promoted to dual faculty appointments in the departments of Cell Biology and Cardiovascular Medicine, where he held the positions of Cardiovascular Director of the Cleveland Clinic Coordinating Center for Clinical Research and the Medical Director of the Atherosclerosis Imaging Core Laboratory and Assistant Professor of Molecular Medicine at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University.
Within SAHMRI Steve is the Director of the Vascular Research Centre, whose mission is to develop new strategies to reduce the risk of heart disease involving a translational program spanning preclinical human and clinical trial research.
He has published more than 390 original manuscripts, conference proceedings and book chapters in journals including the New England Journal of Medicine, JAMA, Lancet and Nature Medicine. He has published two books in the field of cardiovascular medicine. He is the recipient of the Young Investigator Award of the 2003 International Symposium of Atherosclerosis and was a finalist for the Samuel A. Levine Clinical Young Investigator Award at the 2005 Annual Scientific Sessions of the American Heart Association. His research interests span the translational spectrum from the factors influencing the biological activity of HDL, through to development and use of novel plaque imaging modalities and ultimately large scale clinical trials of antiatherosclerotic therapies. He currently is a member of the editorial boards of the European Journal of Preventive Cardiology, Journal of the American College of Cardiology, JACC: Cardiovascular Imaging and Arteriosclerosis, Thrombosis and Vascular Biology.